RxDataScience Revenue and Competitors
Estimated Revenue & Valuation
- RxDataScience's estimated annual revenue is currently $14.9M per year.
- RxDataScience's estimated revenue per employee is $248,917
Employee Data
- RxDataScience has 60 Employees.
- RxDataScience grew their employee count by -39% last year.
RxDataScience's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Project Manager | Reveal Email/Phone |
2 | Project Coordinator | Reveal Email/Phone |
RxDataScience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A | N/A |
#2 | $1.7M | 18 | 0% | N/A | N/A |
#3 | $11.2M | 91 | 20% | N/A | N/A |
#4 | $0.6M | 8 | 0% | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A | N/A |
#6 | $2M | 19 | 0% | N/A | N/A |
#7 | $0.9M | 9 | -10% | N/A | N/A |
#8 | $0.9M | 13 | 30% | N/A | N/A |
#9 | $0.7M | 12 | 33% | N/A | N/A |
#10 | $5.1M | 40 | -5% | N/A | N/A |
What Is RxDataScience?
RxDataScience Inc. is a big data analytics software company focused on creating breakthrough data science products and solutions to deliver business value. We are applying proven advanced analytics and machine learning technologies from industries such as financial services to drive innovation in pharmaceutical and healthcare industries. Our team is comprised of data science and software product development experts with deep knowledge of pharma and healthcare datasets and use cases. We are hiring data scientists, developers, customer support specialists, as well as other roles in our NYC and NC offices so reach out to us if you want to be part of a dynamic, growing company. Our CEO, Larry A. Pickett, Jr. is an Official Member of Forbes New York Business Council.
keywords:N/AN/A
Total Funding
60
Number of Employees
$14.9M
Revenue (est)
-39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $75M | 65 | 14% | N/A |
#2 | $35M | 67 | 6% | N/A |
#3 | $1.7M | 80 | 11% | N/A |
#4 | $13M | 84 | -14% | N/A |
#5 | $16.4M | 88 | 13% | N/A |